A7UmDVyY8iyY9l8ZtGQm

(VTUS) Acquisition of Title to Hemorrhoids Product

  • 0
  • 0

Ventrus BioSciences Incorporated - symbol VTUS - reported that it has completed its acquisition of all rights and title to VEN 309 - iferanserin ointment for the treatment of symptomatic hemorrhoids - from the licensor, Sam Amer & Company.

21 Nov 2011

49 Visualizações

iferanserin, ven309, ventrus, ventrusbiosciences, vtus

Estatísticas do vídeo

Mostrar:

Comentários

Vídeos em Destaque